IP Infusion, Inc., a network provider (RPS) solutions defined and improved software for Ethernet IP services, has announced the availability of VirNOS, a virtual network platform based on the network functions Virtualization (NFV). The solution would enable network operators to reduce CAPEX and OPEX costs, speed time to market for new services, increase agility, and deploy new services faster network.
networking services base Many, including switching, routing, load balancing and VPN , can now be done by the software is running directly on x86-64 or running servers as virtual machines, instead of requiring expensive network equipment.
software platform based on IP Infusion NFV VirNOS virtualizes network functions to give network operators a flexible and cost-effective approach to deploy and manage their networking services.
main features of VirNOS software platform based on NFV include:
- supports the switching flow via OpenFlow for easy deployment of innovative routing and switching protocols
- Uses Intel dpdk to provide the programming framework that scales and allows a more rapid development of high-speed packet data networking applications
- support IPv4 and IPv6 dynamic routing protocols (BGP, OSPF, ISIS, Unicast)
- Exploits basic mature code ZebOS-XP - IP Infusion industry proven platform
- Ideal for virtual machines, high security networks and mobile networks based on next generation IP
"with the new platform VirNOS Infusion IP NFV capabilities, network operators can offer new services more easily networks and services at scale up and down to support their changing business needs, "said Kiyo Oishi, president and CEO of IP Infusion . "We are in partnership with several manufacturers of network equipment to pack our NFV technology in their software offerings that will generate network services more innovative and help their customers to offer new revenue models and growth opportunities."
IP Infusion is headquartered in Sunnyvale, Calif., and is a subsidiary owned and operated independently of ACCESS CO., LTD.
0 Komentar